Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Double-masked, Placebo-controlled Evaluation of Netarsudil for Prevention of Corticosteroid-induced Intraocular Pressure Elevation
Brief Summary: Cornea transplant recipients who are using topical corticosteroids long-term to prevent transplant rejection will be randomized to use netarsudil or placebo.


Options:
A: Arm Label: Netarsudil; Type: EXPERIMENTAL; Interventions: Drug: Netarsudil | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Netarsudil; Assigned to Arm(s): Netarsudil | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: PG324 Ophthalmic Solution 0.02%/0.005%; Type: EXPERIMENTAL; Interventions: Drug: PG324 Ophthalmic Solution 0.02%/0.005% | Arm Label: AR-13324 Ophthalmic Solution 0.02%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Netarsudil (AR-13324) Ophthalmic Solution 0.02% | Arm Label: Latanoprost Ophthalmic Solution 0.005%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Latanoprost Ophthalmic Solution 0.005% | Intervention Type: DRUG; Name: PG324 Ophthalmic Solution 0.02%/0.005%; Assigned to Arm(s): PG324 Ophthalmic Solution 0.02%/0.005% | Intervention Type: DRUG; Name: Netarsudil (AR-13324) Ophthalmic Solution 0.02%; Assigned to Arm(s): AR-13324 Ophthalmic Solution 0.02% | Intervention Type: DRUG; Name: Latanoprost Ophthalmic Solution 0.005%; Assigned to Arm(s): Latanoprost Ophthalmic Solution 0.005%
C: Arm Label: PG324 Ophthalmic Solution 0.02%/0.005%; Type: EXPERIMENTAL; Interventions: Drug: PG324 Ophthalmic Solution 0.02%/0.005% | Arm Label: Netarsudil (AR-13324) ophthalmic solution 0.02%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Netarsudil (AR-13324) ophthalmic solution 0.02% | Arm Label: Latanoprost ophthalmic solution 0.005%; Type: ACTIVE_COMPARATOR; Interventions: Drug: Latanoprost ophthalmic solution 0.005% | Intervention Type: DRUG; Name: PG324 Ophthalmic Solution 0.02%/0.005%; Assigned to Arm(s): PG324 Ophthalmic Solution 0.02%/0.005% | Intervention Type: DRUG; Name: Netarsudil (AR-13324) ophthalmic solution 0.02%; Assigned to Arm(s): Netarsudil (AR-13324) ophthalmic solution 0.02% | Intervention Type: DRUG; Name: Latanoprost ophthalmic solution 0.005%; Assigned to Arm(s): Latanoprost ophthalmic solution 0.005%
D: Arm Label: Netarsudil Ophthalmic Solution 0.01%; Type: EXPERIMENTAL; Interventions: Drug: Netarsudil Ophthalmic Solution 0.01% | Arm Label: Netarsudil Ophthalmic Solution 0.02%; Type: EXPERIMENTAL; Interventions: Drug: Netarsudil Ophthalmic Solution 0.02% | Arm Label: Netarsudil Ophthalmic Solution 0.04%; Type: EXPERIMENTAL; Interventions: Drug: Netarsudil Ophthalmic Solution 0.04% | Arm Label: Netarsudil Ophthalmic Solution Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Netarsudil Ophthalmic Solution Placebo | Intervention Type: DRUG; Name: Netarsudil Ophthalmic Solution 0.01%; Assigned to Arm(s): Netarsudil Ophthalmic Solution 0.01% | Intervention Type: DRUG; Name: Netarsudil Ophthalmic Solution 0.02%; Assigned to Arm(s): Netarsudil Ophthalmic Solution 0.02% | Intervention Type: DRUG; Name: Netarsudil Ophthalmic Solution 0.04%; Assigned to Arm(s): Netarsudil Ophthalmic Solution 0.04% | Intervention Type: OTHER; Name: Netarsudil Ophthalmic Solution Placebo; Assigned to Arm(s): Netarsudil Ophthalmic Solution Placebo

Answer: A